Psychocutaneous disease: Pharmacotherapy and psychotherapy

Helena Kuhn, Constance Mennella, Michelle Magid, Caroline Stamu-O'Brien, George Kroumpouzos

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

Building a strong therapeutic alliance with the patient is of utmost importance in the management of psychocutaneous disease. Optimal management of psychocutaneous disease includes both pharmacotherapy and psychotherapy. This article reviews psychotropic medications currently used for psychocutaneous disease, including antidepressants, antipsychotics, mood stabilizers, and anxiolytics, with a discussion of relevant dosing regimens and adverse effects. Pruritus management is addressed. In addition, basic and complex forms of psychotherapy, such as cognitive-behavioral therapy and habit-reversal training, are described.

Original languageEnglish (US)
Pages (from-to)795-808
Number of pages14
JournalJournal of the American Academy of Dermatology
Volume76
Issue number5
DOIs
StatePublished - May 1 2017

Fingerprint

Disease Management
Psychotherapy
Drug Therapy
Anti-Anxiety Agents
Cognitive Therapy
Pruritus
Antidepressive Agents
Antipsychotic Agents
Habits
Therapeutics

Keywords

  • antidepressant
  • antipsychotic
  • cognitive-behavioral therapy
  • drug
  • management
  • pruritus
  • psychocutaneous
  • psychotherapy

ASJC Scopus subject areas

  • Dermatology

Cite this

Kuhn, H., Mennella, C., Magid, M., Stamu-O'Brien, C., & Kroumpouzos, G. (2017). Psychocutaneous disease: Pharmacotherapy and psychotherapy. Journal of the American Academy of Dermatology, 76(5), 795-808. https://doi.org/10.1016/j.jaad.2016.11.021

Psychocutaneous disease : Pharmacotherapy and psychotherapy. / Kuhn, Helena; Mennella, Constance; Magid, Michelle; Stamu-O'Brien, Caroline; Kroumpouzos, George.

In: Journal of the American Academy of Dermatology, Vol. 76, No. 5, 01.05.2017, p. 795-808.

Research output: Contribution to journalReview article

Kuhn, H, Mennella, C, Magid, M, Stamu-O'Brien, C & Kroumpouzos, G 2017, 'Psychocutaneous disease: Pharmacotherapy and psychotherapy', Journal of the American Academy of Dermatology, vol. 76, no. 5, pp. 795-808. https://doi.org/10.1016/j.jaad.2016.11.021
Kuhn, Helena ; Mennella, Constance ; Magid, Michelle ; Stamu-O'Brien, Caroline ; Kroumpouzos, George. / Psychocutaneous disease : Pharmacotherapy and psychotherapy. In: Journal of the American Academy of Dermatology. 2017 ; Vol. 76, No. 5. pp. 795-808.
@article{b604ac20f057468b93bce21f70708c7f,
title = "Psychocutaneous disease: Pharmacotherapy and psychotherapy",
abstract = "Building a strong therapeutic alliance with the patient is of utmost importance in the management of psychocutaneous disease. Optimal management of psychocutaneous disease includes both pharmacotherapy and psychotherapy. This article reviews psychotropic medications currently used for psychocutaneous disease, including antidepressants, antipsychotics, mood stabilizers, and anxiolytics, with a discussion of relevant dosing regimens and adverse effects. Pruritus management is addressed. In addition, basic and complex forms of psychotherapy, such as cognitive-behavioral therapy and habit-reversal training, are described.",
keywords = "antidepressant, antipsychotic, cognitive-behavioral therapy, drug, management, pruritus, psychocutaneous, psychotherapy",
author = "Helena Kuhn and Constance Mennella and Michelle Magid and Caroline Stamu-O'Brien and George Kroumpouzos",
year = "2017",
month = "5",
day = "1",
doi = "10.1016/j.jaad.2016.11.021",
language = "English (US)",
volume = "76",
pages = "795--808",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "5",

}

TY - JOUR

T1 - Psychocutaneous disease

T2 - Pharmacotherapy and psychotherapy

AU - Kuhn, Helena

AU - Mennella, Constance

AU - Magid, Michelle

AU - Stamu-O'Brien, Caroline

AU - Kroumpouzos, George

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Building a strong therapeutic alliance with the patient is of utmost importance in the management of psychocutaneous disease. Optimal management of psychocutaneous disease includes both pharmacotherapy and psychotherapy. This article reviews psychotropic medications currently used for psychocutaneous disease, including antidepressants, antipsychotics, mood stabilizers, and anxiolytics, with a discussion of relevant dosing regimens and adverse effects. Pruritus management is addressed. In addition, basic and complex forms of psychotherapy, such as cognitive-behavioral therapy and habit-reversal training, are described.

AB - Building a strong therapeutic alliance with the patient is of utmost importance in the management of psychocutaneous disease. Optimal management of psychocutaneous disease includes both pharmacotherapy and psychotherapy. This article reviews psychotropic medications currently used for psychocutaneous disease, including antidepressants, antipsychotics, mood stabilizers, and anxiolytics, with a discussion of relevant dosing regimens and adverse effects. Pruritus management is addressed. In addition, basic and complex forms of psychotherapy, such as cognitive-behavioral therapy and habit-reversal training, are described.

KW - antidepressant

KW - antipsychotic

KW - cognitive-behavioral therapy

KW - drug

KW - management

KW - pruritus

KW - psychocutaneous

KW - psychotherapy

UR - http://www.scopus.com/inward/record.url?scp=85017528880&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017528880&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2016.11.021

DO - 10.1016/j.jaad.2016.11.021

M3 - Review article

C2 - 28411772

AN - SCOPUS:85017528880

VL - 76

SP - 795

EP - 808

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 5

ER -